SJ

Stephen J. Johnson

WC Warner-Lambert Company: 12 patents #115 of 1,610Top 8%
Overall (All Time): #427,877 of 4,157,543Top 15%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
6187808 Hexahydro-naphthalenone oximes and hydrazones Leonard T. Meltzer, Lawrence D. Wise 2001-02-13
6020364 Compounds and method of treating psychosis and schizophrenia David T. Connor, Suzanne Ross Kesten, Steven Robert Miller, Paul C. Unangst, Lawrence D. Wise 2000-02-01
5929064 Amino acid complexes of cobalt (III) mesoporphyrin IX and cobalt (III) protoporphyrin IX Om P. Goel, Lawrence D. Wise 1999-07-27
5922719 Coumarin dopamine D4 receptor antagonists Suzanne Ross Kesten, Lawrence D. Wise, David Juergen Wustrow 1999-07-13
5916914 Compounds and method of treating psychosis and schizophrenia David T. Connor, Suzanne Ross Kesten, Steven Robert Miller, Paul C. Unangst, Lawrence D. Wise 1999-06-29
5486517 Benzimidazoles and imidazopyridines as central nervous system agents Dennis M. Downing, Shelly Glase, Lawrence D. Wise, Jonathan Wright 1996-01-23
5430047 Neurotensin antagonists Suzanne Ross Kesten, Lawrence D. Wise, David Juergen Wustrow 1995-07-04
5409931 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents Bradley W. Caprathe, Dennis M. Downing, Juan C. Jaen, William J. Smith, III, Lawrence D. Wise +2 more 1995-04-25
5314896 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents Bradley W. Caprathe, Dennis M. Downing, Juan C. Jaen, William J. Smith, III, Lawrence D. Wise +2 more 1994-05-24
5066662 Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors Sheila H. Hobbs 1991-11-19
4977172 Method of treating the symptoms of cognitive decline in an elderly patient employing (S)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)-methyl]-2-oxazolidinone Walter H. Moos 1990-12-11
4855316 1,2-diamino-4,5-dimethoxycyclohexyl amide analgesic compounds David C. Horwell 1989-08-08